Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

Managing immunotherapy related adverse events (irAEs) requires a team-based effort, with pharmacists playing an integral role in their identification and management within both outpatient and inpatient multidisciplinary teams.
For patients with pancreatic cancer, clinical trials should be considered as a possible treatment option early on, not a last resort when all else fails. The Let's Win team discusses why.
ACCC recognizes September as Ovarian Cancer Awareness Month in an upcoming webinar series.
Recognizing the effects of SDOH on patients and providers is key as studies show they can impact as much as 80% to 90% of health-related outcomes.
To explore the current state of psychosocial care in oncology, ACCC, with its partners, AOSW and APOS, with support from BeiGene—held a multistakeholder meeting, ACCC’s Call to Action: Delivery of Psychosocial Care in Oncology Summit.
In the past, patients diagnosed with rare cancer types often faced a bleak prognosis due to limited treatment options. Today, the story is different, as advances in precision medicine and the development of new, targeted therapies continue to permeate the oncology space.
In 2012, August 1 was declared World Lung Cancer Day—11 years later, its significance is as important as ever.
By implementing e-consults for patients experiencing endocrine immune-related adverse events, Duke Cancer Institute improved patient access and reduced healthcare utilization.
ACCC is working with multidisciplinary care teams to assess the impact of SDOH on equitable access to cancer care and clinical trials among minority populations.
The survival of pancreatic cancer is 12%, making it one of the deadliest cancers of our time. As a result, understanding the symptoms, risks factors, as well and the benefit of an early diagnosis is key.
Climate change is typically seen through an environmental, political, or socioeconomic lens. Yet it should also be seen as a catastrophic health threat as it will have an effect on the delivery of comprehensive cancer care.
The Collaborative Care Model uses the stepped care approach, enabling a flexible and personalized treatment approach that aligns with each patient’s specific needs.
Virginia Cancer Research Institute successfully implemented a cutting-edge clinical trials navigation program that improved the patient and provider experience and demonstrated a significant return on investment.
This study at Atrium Health, Levine Cancer Institute, highlights the needs of patients with lung cancer and their care partners.
This Colorado-based nonprofit organization offers free therapeutic art sessions to patients with cancer, their caregivers, and long-time cancer survivors.
action 91 OI | Vol. 38, No 4, 2023 | accc-cancer.org Recent years have seen alarming shortages of several anti-cancer drugs that serve as mainstays of treatment. Currently, the Association of Community Cancer Centers (ACCC) is highly concerned about the ongoing shortages of platinum- based chemotherapy agents (e.g., cisplatin and carboplatin), two medications that (individually or in …
The O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham and Monument Health Cancer Care Institute leveraged a technology solution to improve infusion center efficiency, increase revenue, and reduce patient wait times.
In view of the increasing demand for genetic counseling, Aurora Health Care developed this center to better understand the needs of patients with hereditary cancer syndromes.
In the face of an unprecedented drug shortage, Hematology/Oncology Pharmacy Association (HOPA) partnered with the Association of Community Cancer Centers (ACCC) and Association of VA Hematology/Oncology (AVAHO) to lead a virtual round table aimed at developing practical strategies healthcare organizations around the country can adopt.
ACCC set out to identify and understand specific regional challenges to appropriate and equitable care for patients with chronic lymphocytic leukemia, the most common form of leukemia in adults.